The Journal of Immunology, Vol 144, Issue 4 1425-1431, Copyright © 1990 by American Association of Immunologists

ARTICLES

Cytolytic mechanisms of activated macrophages. Tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages

M Higuchi, N Higashi, H Taki and T Osawa
Division of Chemical Toxicology and Immunochemistry, Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

We examined the cytolytic mechanisms of activated macrophages by using proteose peptone- or thioglycollate broth-induced mouse peritoneal macrophages or mouse macrophage hybridomas as effector cells, L.P3 cells, a clone of L929 cells, and P815 cells as target cells, and IFN- gamma and LPS as activators. It was determined that TNF is the main cytolytic molecule against L.P3 cells from the following results: 1) activated macrophages can produce TNF; 2) TNF shows cytotoxic activity against L.P3 cells; 3) the addition of anti-TNF antibody inhibited most of the cytolytic activity of activated macrophages against L.P3 cells. On the other hand, it was concluded that the main cytolytic mechanism against P815 cells is the production of NO2-/NO3- from L-arginine, from the following results: 1) activated macrophages can produce NO2-; 2) NaNO2 shows high cytotoxic activity against P815 cells; 3) the depletion of L-arginine from the medium inhibited most of the cytolytic activity of activated macrophages against P815 cells and NO2- production by activated macrophages. In this study, however, cytostatic effects of L-arginine-dependent effector mechanism were not studied. Thus, these results show that activated macrophages can express at least two cytolytic mechanisms independently, namely, the one that appears to be mediated by the L-arginine-dependent effector mechanism and the second that appears to be mediated directly by TNF. Furthermore, it was demonstrated that TNF and L-arginine-dependent NO2- production act synergistically as killing mechanisms of activated macrophages. These mechanisms can explain the cytolytic activity of activated macrophages against a variety of target cells.

This article has been cited by other articles:

				J. M. Routes, K. Morris, M. C. Ellison, and S. Ryan Macrophages Kill Human Papillomavirus Type 16 E6-Expressing Tumor Cells by Tumor Necrosis Factor Alpha- and Nitric Oxide-Dependent Mechanisms J. Virol., January 1, 2005; 79(1): 116 - 123. [Abstract] [Full Text] [PDF]

				H. Dai, J. Guzman, B. Chen, and U. Costabel Production of Soluble Tumor Necrosis Factor Receptors and Tumor Necrosis Factor-{alpha} by Alveolar Macrophages in Sarcoidosis and Extrinsic Allergic Alveolitis Chest, January 1, 2005; 127(1): 251 - 256. [Abstract] [Full Text] [PDF]

				T. A. Miura, K. Morris, S. Ryan, J. L. Cook, and J. M. Routes Adenovirus E1A, Not Human Papillomavirus E7, Sensitizes Tumor Cells to Lysis by Macrophages Through Nitric Oxide- and TNF-{alpha}-Dependent Mechanisms Despite Up-Regulation of 70-kDa Heat Shock Protein J. Immunol., April 15, 2003; 170(8): 4119 - 4126. [Abstract] [Full Text] [PDF]

				A. Sodhi and S. K. Biswas fMLP-induced in vitro nitric oxide production and its regulation in murine peritoneal macrophages J. Leukoc. Biol., February 1, 2002; 71(2): 262 - 270. [Abstract] [Full Text] [PDF]

				M. Saio, S. Radoja, M. Marino, and A. B. Frey Tumor-Infiltrating Macrophages Induce Apoptosis in Activated CD8+ T Cells by a Mechanism Requiring Cell Contact and Mediated by Both the Cell-Associated Form of TNF and Nitric Oxide J. Immunol., November 15, 2001; 167(10): 5583 - 5593. [Abstract] [Full Text] [PDF]

				F. P. Nestel, R. N. Greene, K. Kichian, P. Ponka, and W. S. Lapp Activation of macrophage cytostatic effector mechanisms during acute graft-versus-host disease: release of intracellular iron and nitric oxide-mediated cytostasis Blood, September 1, 2000; 96(5): 1836 - 1843. [Abstract] [Full Text] [PDF]

				D. M. Page Cutting Edge: Thymic Selection and Autoreactivity Are Regulated by Multiple Coreceptors Involved in T Cell Activation J. Immunol., October 1, 1999; 163(7): 3577 - 3581. [Abstract] [Full Text] [PDF]

				J. A. Melendez, R. P. Melathe, A. M. Rodriguez, J. E. Mazurkiewicz, and K. J. A. Davies Nitric Oxide Enhances the Manganese Superoxide Dismutase-dependent Suppression of Proliferation in HT-1080 Fibrosarcoma Cells Cell Growth Differ., September 1, 1999; 10(9): 655 - 664. [Abstract] [Full Text]

				K. O. Kisich, R. W. Malone, P. A. Feldstein, and K. L. Erickson Specific Inhibition of Macrophage TNF-{alpha} Expression by In Vivo Ribozyme Treatment J. Immunol., August 15, 1999; 163(4): 2008 - 2016. [Abstract] [Full Text] [PDF]